What Is the Treatment of Glycogen Storage Disease Type I?

Glycogen storage disease type I (GSD I) requires a rigorously structured management approach to prevent metabolic decompensation. The central therapeutic challenge is sustaining stable blood glucose continuously, including overnight.

Clinical Goals

The treatment target is maintaining blood glucose at or above 70 mg/dl at all times, while preventing the rapid glucose fluctuations that can drive metabolic instability.

Treatment Approach

First-line management centres on preventing fasting through a carefully structured dietary strategy — specifically, the distribution of carbohydrate-focused feedings across the full 24-hour period. The complete protocol specifies nutrient composition, dietary restrictions, and supplementation requirements not detailed here.

The full regimen — including feeding schedule, carbohydrate targets, restricted dietary components, and supplementation — is available in the structured protocol below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1038/gim.2014.128

Thus, avoidance of fasting is the first line of treatment in GSD I.
To prevent hypoglycemia, small frequent feedings high in complex carbohydrates (preferably those higher in fiber) are evenly distributed over 24 hours.
The aim should be to keep BG ≥70 and to avoid rapid glucose fluxes.
Maintaining blood glucose levels ≥70 mg/dl is important to achieve good metabolic control.

View source ↗